Thursday , 7 November 2024
Home CTLA-4

CTLA-4

PD-1 Antibody Targeting Immune Checkpoint Inhibition
Healthcare

Cancer Treatment’s New Hope: Checkpoint Inhibitors

Two decades ago, patients with aggressive cancers faced grim prognoses, as treatment options were limited. However, a paradigm shift occurred with the introduction...